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Pseudomonas aeruginosa is a pathogen in both humans and animals. This bacterium, most often associated
with respiratory infections in cystic fibrosis patients, was found to be the causative agent in bovine mastitis
outbreaks among 11 Irish dairy herds. Epidemiological findings suggested that the infection was spread to all
herds by teat wipes that had been contaminated with this organism. Two molecular-typing strategies were used
in an attempt to determine the genomic relationship(s), if any, of the P. aeruginosa strains isolated from the
various herds and to verify whether the same strain was responsible for each outbreak. Thirty-six isolates from
the mastitis outbreaks were tested and compared to fourteen clinical isolates from Cork University Hospital.
With one exception, all outbreak-linked strains produced identical patterns when ribotyped with ClaI and PvuII
enzymes. Eight of the clinical isolates gave the same ClaI ribotype pattern as the mastitis-causing strains.
However, PvuII proved more discriminatory, with only the outbreak isolates producing identical patterns.
Similar results were obtained with RW3A-primed DNA amplification fingerprinting, with all outbreak isolates
except one displaying the same fingerprint array. The clinical strains produced several fingerprint patterns, all
of which were different from those of the mastitis-causing isolates. Fine-resolution DNA fingerprinting with a
fluorescence-labelled RW3A primer also identified a number of low-molecular-weight polymorphisms that
would have remained undetected by conventional methods. These data support the view that the same P. aeru-
ginosa strain was responsible for the mastitis outbreaks in all 11 herds.
Pseudomonas aeruginosa is a gram-negative pathogen. This
bacterium is frequently responsible for nosocomial infections
in humans, particularly in cystic fibrosis (CF) (9) and burn
patients. P. aeruginosa has also been identified as an animal
pathogen and as the occasional cause of bovine mastitis. In
cases of P. aeruginosa mastitis, the bacterium has been de-
tected in contaminated wash hoses in milking parlors, in water
and spray nozzles, and in contaminated antibiotic preparations
(20). The ability to survive in moist environments contributes
greatly to this organism’s ubiquitous presence in nature (5, 11).
Standard laboratory identification of Pseudomonas spp. is
usually based on assessment of colony morphology and oxidase
tests. Identification at the species level is obtained by using
pyocin typing, antibiogram analysis, O-antigen serotyping, and
biochemical tests such as the API 20NE (bioMe´rieux, Marcy
l’Etoile, France) identification system (6, 12). Many P. aerugi-
nosa strains, particularly those associated with CF patients,
have aberrant phenotypic characteristics, and conventional typ-
ing methods often prove ineffective (18). For successful epide-
miological evaluation and the development of effective treat-
ment programs, a definitive typing method which facilitates
rapid and reliable strain identification is necessary.
It is well recognized that phenotypic typing methods may not
correlate with genetic variation (3, 18). However, typing iso-
lates at the molecular level is generally regarded as a sensitive
and discriminating approach. Among the molecular typing
techniques applied to P. aeruginosa, ribotyping, in which pat-
terns produced after digestion and blotting of ribosomal genes
are analyzed, is frequently used (1, 7). Pulsed-field gel electro-
phoresis is another technique often employed for typing bac-
terial isolates (7). Other methods based on Southern blotting
have used toxA-specific (17) and pilin gene-specific (22) probes.
More recently, methods based on PCR have been developed
for the comparative typing of P. aeruginosa (1, 7, 8, 10, 13, 14,
16, 21).
Cork Regional Veterinary Laboratory (CRVL) is situated in
the most intensive dairy-producing region of Ireland, with over
400,000 dairy cows in its catchment area. Prior to the outbreaks
reported in this paper, only one herd outbreak of P. aeruginosa
mastitis had been diagnosed by CRVL in 25 years. In that
outbreak, contaminated water was implicated as the source of
the bacterium (19a). In the autumn of 1995, a pharmaceutical
company sales promotion offered free tubs of teat wipes with
the purchase of dry cow therapy (DCT) tubes. The tubs of
wipes were sealed and contained 120 wipes in 70% ethanol.
The purpose of the wipes was to clean and sterilize the teat end
before the infusion of DCT antibiotic into the mammary gland
via the teat opening. In autumn of 1996, some of these pro-
motional tubs of wipes were still available.
From November 1996 to May 1997, CRVL investigated out-
breaks of mastitis in 11 herds. The promotional wipes had been
used on all of the herds during the administration of DCT.
Tubs of the wipes used for each of 10 of the herds were
available for testing at the time of investigation. An unopened
tub of wipes with an intact seal was also obtained from the
manufacturer. Standard bacteriological examination of both
milk samples from infected cows and the wipes was under-
taken. P. aeruginosa isolates with consistent API 20NE biotype
profiles were identified in all the wipes cultured. The cultured
milk samples indicated that the organism was present in all
herds, albeit with slight inconsistencies in the API 20NE bio-
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profiles of some isolates. This organism was easily cultured
from acute mastitis cases in both dry and freshly calved cows,
but it was more difficult to isolate from chronic mastitis cases
in lactating cows, possibly because of low concentrations of the
organism and intermittent excretion. All isolates were resistant
to the standard antibiotics used in mastitis treatment.
As part of an epidemiological investigation of 11 mastitis out-
breaks in which P. aeruginosa had been detected, ribotype anal-
ysis and DNA amplification fingerprinting (DAF) were under-
taken. This paper presents the findings of these experiments
and discusses the utility of molecular surveillance methods.
MATERIALS AND METHODS
Bacterial isolates. A total of 50 Pseudomonas isolates were used in this study
(Table 1), and 36 of the isolates were P. aeruginosa obtained from the bovine
mastitis outbreak under investigation. A selection of 14 control Pseudomonas
organisms were obtained from the Department of Medical Microbiology, Cork
University Hospital (CUH) for comparison. These controls included P. aerugi-
nosa ATCC 27853, Pseudomonas spp. isolated from a variety of clinical cases,
and isolates cultured from CF patients. Four of the hospital isolates were iden-
tified as P. aeruginosa based on their colony morphology, antibiogram typing, and
API 20NE biotyping. The remaining 10, known to be Pseudomonas spp. (gram-
negative, oxidase-positive bacilli in often-mucoid colonies with production of
green pigment and a characteristic odor) were not further characterized. All
isolates were stored on nutrient agar slopes at 4°C and, when required, were
grown in tryptic soy broth (Oxoid, Basingstoke, Hampshire, United Kingdom).
The isolates were also maintained on cryostat beads (Mast Diagnostics, Mersey-
side, United Kingdom) at 220°C for long-term storage.
DNA isolation. Bacterial cells were grown in 5 ml of tryptic soy broth overnight
at 37°C, and DNA was extracted as previously described (23) with minor mod-
ifications. Bacterial cells were centrifuged at 14,000 3 g for 5 min and washed in
1 ml of 1 M NaCl. Following centrifugation, the cells were washed in 1 ml of a
TE buffer (50 mM Tris-HCl [pH 8.0], 50 mM EDTA), centrifuged at high speed,
and resuspended in 0.7 ml of the same TE buffer. Two hundred micrograms of
lysozyme (Sigma, St. Louis, Mo.) was added, and the mixture was incubated at
37°C for 30 min. Thirty microliters of 20% sodium dodecyl sulfate was added,
and the mixture was incubated at 65°C for 10 min. To complete the lysis, 60 ml
of proteinase K (10 mg/ml) (Sigma) was added and the mixture was incubated at
37°C for 1 h. Cell lysates were extracted twice with 1 ml of a phenol-chloroform
solution. DNA was precipitated from the aqueous phase with 0.33 M NH4-
acetate and 2.5 volumes of cold ethanol overnight at 220°C. The precipitated
DNA was then dissolved in a TE buffer (10 mM Tris-HCl [pH 8.0], 1 mM
EDTA). The integrity of the extracted DNA was assessed by electrophoresis in
a 1% agarose gel, and the DNA concentration was measured spectrophotometri-
cally as the A260.
Ribotyping. The restriction endonucleases ClaI and PvuII (New England Bio-
labs, Beverly, Mass.) were chosen for digestion of the Pseudomonas genomic
DNA. Briefly, 2.0 mg of DNA was cleaved with each enzyme according to the
manufacturer’s instructions. The digests were electrophoresed at 25 V overnight
in 0.8% SeaKem IDNA agarose gels (FMC, Rockland, Maine) in a GNA 200
apparatus (Pharmacia, Uppsala, Sweden). Digoxigenin (DIG)-labelled lambda
phage DNA digested with HindIII (Boehringer Mannheim GmbH, Mannheim,
Germany) was used as a molecular weight marker.
After electrophoresis, DNA was transferred to nylon membranes (Sigma-
Aldrich, Deisenhofen, Germany) with the VacuGene XL blotting system (Phar-
macia), following the protocol recommended by the manufacturer. All mem-
branes were air dried, and DNA was cross-linked by UV irradiation in a
Spectrolinker XL 1000 (Spectronics Corporation).
A cDNA probe was prepared from Escherichia coli 16 and 23S rRNA (Boehr-
inger) by using avian myeloblastosis virus reverse transcriptase (Promega, Mad-
ison, Wis.) (2). This probe was DIG labelled by incorporating the DIG-dUTP
(Boehringer) nucleotide into the reaction. The probe was then used for hybrid-
ization to rRNA sequences at 60°C in a hybridizer (Techne, Cambridge, United
Kingdom). Hybridization, washing, and color development of the membrane
were carried out as described by Popovic et al. (19).
RW3A-DNA amplification fingerprinting. All PCRs were performed in final
volumes of 50 ml each, containing 300 ng of genomic DNA, 100 pmol of RW3A
primer (derived from a repetitive element in the genome of Mycoplasma pneu-
moniae [25]), 5 ml of 103 PCR buffer (100 mM Tris-HCl [pH 9.0], 500 mM KCl,
1% Triton X-100), 8 ml of deoxynucleotide triphosphate mix (consisting of 1.25
mM [each] dATP, dCTP, dGTP, and dTTP), 2.5 mM MgCl2, 0.5% dimethyl
sulfoxide (Sigma), and 2.5 U of Taq DNA polymerase (Sigma). The RW3A
primer (59-TCG CTC AAA ACA ACG ACA CC-39) (4) was synthesized and
polyacrylamide gel purified by Eurogentec (Abingdon, United Kingdom). Each
reaction was amplified in a MiniCycler (MJ Research) by using the following
temperature profile: predenaturation at 94°C for 2 min followed by 35 cycles of
94°C for 1 min, 54°C for 1 min, and 72°C for 2 min and a final extension step at
72°C for 5 min. Each amplification reaction included a negative control which
contained all reagents except the target DNA. Amplified DNA products were
resolved by conventional electrophoresis through horizontal 2% agarose gels at
100 V, and the results were visualized and photographed over a UV transillu-
minator. Analysis of all isolates was performed in duplicate, with some isolates
being analyzed in triplicate. All results were reproducible.
GeneScan-mediated DNA fingerprint analysis. Following analysis by conven-
tional agarose gel electrophoresis of the DNA fingerprints generated with the
RW3A primer, a group of these isolates were chosen for GeneScan analysis.
Isolates were taken from the outbreak group, which displayed identical patterns,
and from the hospital collection, which displayed different patterns, and were
used for comparison. For GeneScan analysis, RW3A PCR fingerprinting was
performed as outlined above, except that the primer was 59-end labelled with the
fluorescent dye (F) 6-carboxyfluorescine. It was necessary to purify the PCR
products with a QIAquick PCR Purification kit (Qiagen, Ltd., West Sussex,
United Kingdom) prior to scanning. Samples were prepared for GeneScan anal-
ysis by mixing 0.5 ml of the F-labelled PCR-purified product, 0.5 ml of GeneScan
TABLE 1. Pseudomonas isolates typed with ClaI and PvuII
ribotyping and RW3A DNA fingerprinting
Outbreak
case no.a
Strain
no.b
Origin of
strainc
RW3A
DAF
Ribotyped
ClaI PvuII
1 ATCC 27853 Control I I I
CIT-V2 2713 Mastitis outbreak II II II
CIT-V3W 2111 Mastitis outbreak II II II
CIT-V4 1278 Mastitis outbreak II II II
CIT-V5 3704 Mastitis outbreak II II II
CIT-V6W 1590 Sealed tub II II II
CIT-V7 1670 Mastitis outbreak II II II
CIT-V8W 1754 Mastitis outbreak II II ND
CIT-V9 3507 Mastitis outbreak II II II
CIT-V10W 1171 Mastitis outbreak II II II
CIT-V11 2865 Mastitis outbreak II II II
CIT-V12 1945 Mastitis outbreak II II ND
CIT-V13W 2304 Mastitis outbreak II II II
CIT-V14 6023 (677) Mastitis outbreak II II II
CIT-V15 3450 (3) Mastitis outbreak III III III
CIT-V16 6023 (731) Mastitis outbreak II II II
CIT-V17 2375 Mastitis outbreak II II II
CIT-V18 2379 Mastitis outbreak II II II
CIT-V19W 1752 Mastitis outbreak II II II
CIT-V20W 1663 Mastitis outbreak II II II
CIT-V21 1776 Mastitis outbreak II II II
CIT-V22 1715 Mastitis outbreak II II II
CIT-V23W 2166 Mastitis outbreak II II II
CIT-V24 1753 (6) Mastitis outbreak II II ND
CIT-V25 2851 Mastitis outbreak II II II
CIT-V26 2599 Mastitis outbreak II II II
CIT-V27W 3042 Mastitis outbreak II II II
CIT-V28 1753 (2) Mastitis outbreak II II II
CIT-V29 6023 (5) Mastitis outbreak II II II
CIT-V30W 2728 Mastitis outbreak II II ND
CIT-V31 6023 (743) Mastitis outbreak II II II
CIT-V32 6043 (529) Mastitis outbreak II II II
CIT-V33 6023 (712) Mastitis outbreak II II II
CIT-V34 6023 (627) Mastitis outbreak II ND II
CIT-V35 3040 (601) Mastitis outbreak II II II
CIT-V36 3040 (2) Mastitis outbreak II II II
CIT-H1 33454 Ear swab IV IV IV
CIT-H2 33937 CF patient V II V
CIT-H3 33977 NA VI II VI
CIT-H4 33977 NA VI II VI
CIT-H5 33938 (2) CF patient VII IV VII
CIT-H6 33938 CF patient VIII IV VII
CIT-H7 33936 CF patient IX II VIII
CIT-H8 33967 Leg ulcer X II VI
CIT-H9 33424 NA VI II IX
CIT-H10 33947 Leg ulcer XI V X
CIT-H11 33535 Ear swab XII VI XI
CIT-H12 33588 Leg ulcer XIII II XII
CIT-H13 33534 Ear swab XIV VI XIII
CIT-H14 33617 NA VI II IX
a V, veterinary isolate; H, hospital isolate; W, wipe isolate.
b Numbers in parentheses indicate animal number.
c NA, not available; sealed tub, tub unbroached before testing.
d ND, not determined.
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6-carboxy-X-rhodamine-labelled 2500 internal standards (Applied Biosystems,
Warrington, United Kingdom), and 12 ml of high-pressure liquid chromatogra-
phy-purified water. All appropriate cathode and anode buffers for electrophore-
sis were prepared in an ABI Prism 310 genetic analyzer according to the man-
ufacturer’s recommendations. Each sample was automatically electroinjected
into a 50-cm capillary containing a 2.5% polyacrylamide matrix and electropho-
resed for 15 min at 11 kV at 30°C. F-labelled PCR products were excited by an
argon laser, and the emitted radiation was captured and analyzed by the system
software. RW3A-generated DNA amplicons were automatically sized by com-
parison with the internal standards, and all data were stored in a digital format
on a dedicated computer (Macintosh PowerMac; Apple, Cuppertino, Calif.).
RESULTS
Ribotyping. Genomic DNA from all 50 Pseudomonas iso-
lates was digested with ClaI and PvuII restriction endonucle-
ases. After hybridization with the 16 and 23S rRNA cDNA
probe, ribotype patterns were detected in each sample, with
bands ranging from 6.5 to 23 kb after digestion with ClaI (Fig.
1) and from 2.3 to 23 kb after digestion with PvuII (data not
shown). Some of the bands appeared weak or differed between
gels and were not considered further. The latter did not
present a problem for interpretation, as the patterns derived
from the stronger bands were both stable and reproducible.
With one exception (CIT-V15; Fig. 1, lane 7), all strains
linked to the outbreak produced identical ribotype patterns,
suggesting that the 16 and 23S rRNA interspacer regions were
conserved among these isolates. ClaI banding patterns for
eight of the clinical isolates were also identical to the mastitis-
linked strains (Fig. 1, lanes 9, 10, 15, 16, 19, and 21). However,
by using PvuII, the outbreak pattern was confined to the mas-
titis-linked isolates. These eight clinical isolates were further
classified into five subgroups, with CIT-H3, -H4, and -H8 com-
prising the largest group. The isolates CIT-H9 and -H14 com-
prised the next largest group, while three individual patterns
for CIT-H2, -H7, and -H12 were noted (Table 1). Isolate
CIT-V15 (Table 1) clearly displayed a ribotype pattern after
digestion with ClaI and PvuII enzymes that was different from
those of the remaining 35 outbreak isolates and the CUH
clinical strains (Fig. 1, lane 7). This finding suggests that on the
basis of ribotyping, CIT-V15 cannot be implicated as being
involved in the outbreak. This observation was further con-
firmed by DAF analysis (see below).
RW3A-primed DNA fingerprinting. Total genomic DNA
was extracted from all 50 Pseudomonas isolates by using a
modified version of the protocol by Versalovic et al. (23). All
strains were successfully amplified by using PCR. Typically, the
DNA fragments visualized after ethidium bromide staining
ranged from approximately 100 bp to 1.3 kbp (Fig. 2), with an
average of seven amplicons per gel lane. Several different group-
ings existed within the collection, each displaying a unique
DNA banding array.
The P. aeruginosa ATCC 27853 control strain produced a
unique pattern which was designated group I (Fig. 2, lane 1).
All of the mastitis outbreak-linked strains had identical pat-
terns and were designated group II (representative isolates are
shown in Fig. 2, lanes 2 to 4), with the exception of CIT-V15
(Table 1), which clearly exhibited a unique DNA fingerprint
and was designated group III (Fig. 2, lane 5). The fact that
these isolates had corresponding DNA patterns is consistent
with a clonal origin for these organisms. In comparison, the
CUH clinical isolates could be divided into a number of
groups, reflecting the genomic diversity of these strains (Fig. 2,
lanes 6 through 17).
F-RW3A GeneScan analysis. As the banding patterns for all
mastitis-linked isolates obtained after conventional agarose gel
analysis appeared to be identical and because this method is
incapable of adequately resolving DNA amplicons of low mo-
lecular weight, a fluorescence-based strategy was used to in-
vestigate whether the low-molecular-weight range contained
polymorphic DNA fragments. The inclusion of an F-labelled
RW3A primer in the fingerprinting reaction generated DNA
amplicons with fluorescent labels attached after amplification.
Use of the GeneScan ABI Prism 310 genetic analyzer offers a
finer approach to analyzing DNA fragments in the low-molec-
ular-weight range. Furthermore, all F-labelled amplicons can
be detected and automatically sized directly against a suitable
internal lane size standard.
Representative outbreak isolates (groups II and III), clinical
isolates (groups V, VIII, and XI), and the control strain (group
FIG. 1. Ribotype patterns of a representative selection of Pseudomonas isolates after digestion with ClaI. Molecular weight markers ([DIG]-labelled lambda phage
DNA fragments digested with HindIII [Boehringer]) are shown in lanes M. Lane 1, ATCC 27853 (group I); Lane 2, CIT-V2 (II); lane 3, CIT-V3 (II); lane 4, CIT-V4
(II); lane 5, CIT-V5 (II); lane 6, CIT-V6 (II); lane 7, CIT-V15 (III); lane 8, CIT-H1 (IV); lane 9, CIT-H2 (II); lane 10, CIT-H3 (VI); lane 11, CIT-H4 (II); lane 12,
CIT-H5 (IV); lane 13, CIT-H6 (IV); lane 14, CIT-H7 (II); lane 15, CIT-H8 (II); lane 16, CIT-H9 (II); lane 17, CIT-H10 (V); lane 18, CIT-H11 (VI); lane 19, CIT-H12
(II); lane 20, CIT-H13 (VI); and lane 21, CIT-H14 (II). Numbers in parentheses denote ribotype groups.
FIG. 2. DNA fingerprint patterns of representative Pseudomonas isolates
typed with the primer RW3A. PCR products (10-ml volumes) were loaded onto
a 2% agarose gel in 13 Tris-acetate-EDTA buffer containing 0.1 mg of ethidium
bromide per ml. Samples were electrophoresed at 100 V for 90 min. Lanes M
contain molecular weight markers (grade III; Boehringer). Lane M* contains a
mixture of molecular weight markers (grades III and V). Lane 1, ATCC 27853
(group I); lane 2, CIT-V2 (II); lane 3, CIT-V3 (II); lane 4, CIT-V4 (II); lane 5,
CIT-V15 (III); lane 6, CIT-H1 (IV); lane 7, CIT-H2 (V); lane 8, CIT-H3 (VI);
lane 9, CIT-H5 (VII); lane 10, CIT-H6 (VIII); lane 11, CIT-H7 (IX); lane 12,
CIT-H8 (X); lane 13, CIT-H9 (VI); lane 14, CIT-H10 (XI); lane 15, CIT-H11
(XII); lane 16, CIT-H12 (XIII); and lane 17, CIT-H13 (XIV). Numbers in
parentheses denote DAF groups.
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I) were used for GeneScan analysis. The outbreak isolates
were chosen because they displayed identical patterns in stan-
dard agarose gels. A selection of the scan patterns is shown in
Fig. 3. All of these patterns were scanned from 55 bp to 4.5
kbp. When the mastitis-linked strains were compared, several
RW3A-derived DNA fragments (blue peaks) were found to be
conserved between all isolates. This observation was also true
of other Pseudomonas spp. in the collection. These presump-
tive monomorphic fragments were conserved at a number of
positions within the scan window (indicated by the hatched
bars in Fig. 3) and were located in the size ranges from 379 to
488 bp and from 1,199 to 1,740 bp. Furthermore, the peaks
FIG. 3. GeneScan traces of Pseudomonas isolates. Blue peaks represent 6-carboxyfluorescine-labelled RW3A-generated DNA fragments which were sized by direct
comparison with the 6-carboxy-X-rhodamine-labelled internal standards (red peaks). The size range is indicated by the solid red arrowheads below the final trace.
Regions of interest within the Pseudomonas genome are indicated by hatched and open bars and a solid blue bar for some isolates. Polymorphic DNA fragments are
denoted by the solid green peak with corresponding molecular lengths.
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obtained with the control strain (ATCC 27853) and with CIT-
V15, -H2, -H6, and -H9 showed variable heights. Although all
PCR and scan profile conditions were standardized, the latter
observation may be consistent with quantitative polymor-
phisms. Careful examination of the scan traces identified an-
other cluster of bands (indicated by the solid blue bar in Fig.
3), found in only the control strain and the two outbreak strains
analyzed. These peaks may represent functionally significant
conserved regions within the Pseudomonas genome. Interest-
ingly, the double peak observed between 379 and 488 bp in all
traces (Fig. 3, hatched bar) is position shifted in CIT-V15 (Fig.
3, open bar), with lengths of 431 and 446 bp assigned to these
DNA fragments, respectively. This finding suggests that when
CIT-V15 is compared to the other outbreak strains, a struc-
tural genomic difference is revealed within this region, which
may be consistent with the results from ribotyping and pulsed-
field gel electrophoresis (data not shown) that exclude this
isolate from the outbreak-causing groups.
Several polymorphic DNA bands were also identified (Fig.
3), the significance of which is currently under investigation.
Finally, comparison of the GeneScan patterns for the CUH
clinical isolates demonstrated a greater degree of heterogene-
ity within the size range scanned. This finding is similarly re-
flected in the ribotype and original DNA fingerprint data.
DISCUSSION
Eleven outbreaks of bovine mastitis in County Cork in the
southern region of Ireland were investigated by standard
laboratory methods and refined DNA-based techniques. Lab-
oratory findings and clinical history suggested that P. aerugi-
nosa-contaminated teat wipes were the cause of the mastitis
FIG. 3—Continued.
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outbreaks. The probable sequence of events was that P. aerugi-
nosa-contaminated wipes were rubbed on the teat, and the
bacteria deposited at the teat opening were subsequently in-
troduced into the teat lumen by the nozzle of a DCT antibiotic
tube. As no P. aeruginosa outbreaks had been diagnosed fol-
lowing the 1995 lactation period, we suggest that tubs of teat
wipes were contaminated with very low concentrations of
P. aeruginosa at the manufacturing stage, and multiplication of
the bacterium occurred through 1996. Although none of the
wipes used for one herd remained at the time of investigation,
the putative clonal P. aeruginosa was obtained from this herd
directly from milk samples CIT-V2 and CIT-V11 (Table 1).
All strains were first identified as P. aeruginosa by standard
laboratory methods. It proved difficult to obtain additional
information concerning the relationship between these strains
with the commonly used API 20NE biotyping methods. In
attempting to establish whether a genetic relationship existed
among the isolates cultured, we used two molecular-typing
strategies in this investigation. These were ribotyping, which
samples the interspacer regions between the 16 and 23S rRNA
genes, and DNA fingerprinting, which analyzes the complete
genome based on the amplification of conserved motif plat-
forms, such as the M. pneumoniae repeat sequence MP-2 (25).
With the exception of isolate CIT-V15, recovered from one
of the infected herds, the molecular-typing methods applied in
this study found all P. aeruginosa isolates from this mastitis
outbreak to be identical at the genomic level. When all isolates
were ribotyped with ClaI, the outbreak isolates displayed con-
served patterns. Similarly, eight of the clinical isolates were
found to have the same ribotype pattern as the mastitis out-
break isolates. This pattern similarity can be explained by the
recognized stability of the inter-ribosomal gene spacer regions
of these isolates (1, 15).
Analysis of the DAF patterns by using the MP-2 repeat
sequence (25) as a target to amplify interrepeat regions of the
Pseudomonas genome was found to be a more sensitive ap-
proach, capable of detecting genomic differences among iso-
lates. All mastitis-linked isolates except CIT-V15 displayed
identical DNA banding patterns in conventional agarose gels,
producing bands ranging from 267 bp to 1.3 kbp. Furthermore,
this technique allowed the hospital isolates within the collec-
tion to be divided into several groups based on the comparison
of ribotype data. Taken together, all of these data supported
the clonal nature of these P. aeruginosa-linked mastitis out-
breaks.
It is anticipated that sensitive and discriminating typing pro-
tocols will become an essential component of an overall infec-
tion control policy. A necessary part of any widespread policy
based upon molecular-typing methods is the establishment of
universally accepted laboratory protocols which allow inter-
laboratory comparisons. To date, no universal protocol has
emerged, and we believe that this will continue to be the case.
Recent advances in automated DNA sequencing technologies
have facilitated the development of F-labelled DNA finger-
print detection strategies. Essentially, F-labelled PCR products
were analyzed in this study by using the capillary-based ABI
Prism 310 GeneScan analyzer after in vitro enzyme-mediated
amplification. Genome comparisons were made based on the
electropherogram output for each isolate, in which all peaks
were automatically sized by comparison with known internal
standards. Capillary electrophoresis offers several advantages
over the cumbersome preparation of polyacrylamide gels re-
quired for analogous instruments (e.g., ABI Prism 373/377).
Automated F detection clearly provides finer resolution (4, 24)
than standard agarose gels. An additional advantage is the
possibility of using differentially labelled primers for multiplex-
ing, thereby increasing the sensitivity and discriminating power
of this strategy. In a more recent development, it is now pos-
sible to directly compare strain genome-derived fingerprints by
linking them to an electronic DNA fingerprint, a process which
will greatly improve pathogen tracking (5a).
In conclusion, this study examined the genetic relationship
of 36 P. aeruginosa isolates which were being investigated by
CRVL as the etiological agent in localized mastitis outbreaks
in Irish dairy herds. By ribotype analysis and DNA fingerprint-
ing (with conventional agarose and high-resolution electro-
phoresis) of the genomes of all strains recovered, we found 35
of the isolates to be genetically identical. These data support a
clonal nature for this outbreak and highlight the utility of
molecular surveillance methods for the investigation of poten-
tial infection linkages among organisms. In the future, these
strategies will facilitate disease control monitoring and allow a
more complete understanding of organism epidemiology and
target intervention(s) when appropriate.
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